Concepedia

Sam L. Koprak

SL

10

Publications

1.8K

Citations

10

H-Index

1990

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sam L. Koprak is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1990–2005

10

Publications

10

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak et al. · The Journal of Immunology · 1990 · 607 citations

The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.

Francis J. Dumont, Michael Melino, Mary Jo Staruch et al. · The Journal of Immunology · 1990 · 355 citations · Full text

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.

Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak et al. · The Journal of Experimental Medicine · 1992 · 253 citations · Full text

, , +19

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

N H Sigal, Francis J. Dumont, P. L. DURETTE et al. · The Journal of Experimental Medicine · 1991 · 249 citations · Full text

, , +18

Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells

Jenny Xie, Naomi Nomura, Sam L. Koprak et al. · The Journal of Immunology · 2003 · 118 citations

, , +16

Rows per page

1–5 of 10